New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas. The effects of the IRA will have a far more serious impact on the development of new medicines than has been reported, according to the research.Continue reading
Category Archives: Advocacy and Regulations
KOL Conversation: The Impact of the IRA on Oncology Patient Care
Impact of the IRA on Oncology Patient Care features an interview with Dr. Barbara L. McAneny, MD, FASCO, MACP Former President for the American Medical Association and the New Mexico Medical Society (NMMS); and currently CEO, New Mexico Cancer Center.
With Dr. Steve Potts CEO, Anticipate Bioscience.
Impact of the IRA on Oncology Patient Care was recorded on the 26th of May 2023Continue reading
AZ Budget Update: See where Arizona is spending and investing in FY24
Arizona Gov. Katie Hobbs has signed Arizona’s FY24 budget. The state’s $17.8 billion spending plan includes money to prevent homelessness, boost education funding and send tax rebates to parents. It also includes some interesting and, in some cases, surprising additions or omissions. Continue reading
How You Can Impact Arizona’s Innovation Future
Grass roots advocacy is when people engage in the legislative process by sharing their views with their elected leaders. It can take the form of writing or signing on to letters, testifying at hearings, attending town halls, visiting an elected leader at their office; or, here in Arizona, sharing their position on bills at the Legislature using the Request to Speak System. Continue reading
Funding for the Arizona Health Innovation Trust Fund Passes in Senate Appropriations
The Arizona Health Innovation Trust Fund (AHIT) was established in 2022 to develop workforce programs; support small health innovation businesses; and provide other financial support that will drive growth in Arizona’s life science sector. On February 23, 2023, SB1084 was amended to appropriate $50 million in funding for AHIT in Arizona’s FY24 budget and declares that the Legislature intends that the Fund steadily grows to maintain a permanent endowment balance of at least $200 million. The amended bill received a Do Pass as Amended recommendation. SB1084 now moves to consideration by the Senate Rules Committee.Continue reading
Updates to Arizona’s R and D Tax Credits Under Consideration at Arizona Legislature
On February 23,2023, the Arizona Senate Appropriations gave a Do Pass Recommendation to SB1562 which updates and expands Arizona’s R&D Tax Credit program.Continue reading
Game Changer: The Arizona Health Innovation Trust Fund
Established in 2022, the Arizona Health Innovation Trust Fund (AHIT) is designed to help Arizona become home to a top-ten life science sector by helping to bridge the “valley of death.” During the 2023 legislative session, our elected leaders have the opportunity to make the investment that will capitalize the AHIT. Continue reading
Arizona’s Opportunity to Drive Health Innovation Forward Faster
In 2022, Arizona established the Arizona Health Innovation Trust Fund as a vehicle to drive the creation of health innovations that can improve quality of life for people of Arizona and increase opportunities for the high quality jobs Arizona Health Innovators create. The FY2023 appropriation was $100,000 to allow the initial set up of the fund. In 2023, two bills at the Arizona Legislature (HB2253 and SB1084) propose a $200 million dollar one-time investment into the Arizona Health Innovation Trust Fund.Continue reading
Arizona Legislative Leaders Discuss The Road Ahead
In 2023, Arizona will welcome a new governor and a new legislature. Watch the video for insights shared by Arizona’s incoming Senate President Pro Tem and incoming House Democratic Leader as they discuss the road ahead.
Recorded at the AZBio Trailblazers Luncheon on December 15, 2022. Continue reading
The IRA is now law. What comes next?
AZBio President & CEO, Joan Koerber-Walker provides a brief overview of the provision of the Inflation Reduction act of 2022 (The IRA) from the patient and health innovation perspective and is then joined by health innovator and drug developer, Dr. Steven J. Potts, for a discussion of the potential unintended consequences of some provisions of The IRA relating to the future health innovation landscape.Continue reading